RENAL ALLOGRAFT OUTCOMES IN LIVE DONOR RECIPIENTS ON TACROLIMUS BASED TRIPLE IMMUNOSUPPRESSION WITH AND WITHOUT BASILIXIMAB INDUCTION

被引：0
|
作者：
Sakhuja, Vinay [1 ]
Gundlapalli, Srikanth [1 ]
Rathi, Manish [1 ]
Jha, Vivekanand [1 ]
Kohli, H. S. [1 ]
Sharma, Ashish [1 ]
Minz, M. [1 ]
机构：
[1] PGIMER, Chandigarh, India
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：513 / 513
页数：1
相关论文
共 50 条
  • [21] Comparative Study of the Cellular Pharmacodynamics of Tacrolimus in Renal Transplant Recipients Treated With and Without Basiliximab
    Sugiyama, Kentaro
    Isogai, Kazuya
    Horisawa, Satoshi
    Toyama, Akira
    Satoh, Hiroshi
    Saito, Kazuhide
    Nakagawa, Yuki
    Tasaki, Masayuki
    Takahashi, Kota
    Hirano, Toshihiko
    CELL TRANSPLANTATION, 2012, 21 (2-3) : 565 - 570
  • [22] Three Year Outcomes of Renal Allograft Transplants in African American Recipients Receiving Alemtuzumab for Induction Immunosuppression
    Vaitla, P.
    Bohorquez, H.
    Cohen, A.
    Cruz, A.
    Patel, U.
    Anders, S.
    Catherine, C. -S.
    Moiz, A.
    Guisti, S.
    Carmody, I.
    Loss, G.
    Bruce, D.
    Reichman, T.
    Garces, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [23] Immunoprophylaxis with anti-interleukin-2 receptor monoclonal antibodies and triple immunosuppression in deceased donor renal allograft recipients
    Grego, K.
    Bren, A. F.
    Kandus, A.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2006, 29 (03): : 192 - 192
  • [24] PRETREATMENT OF RENAL-ALLOGRAFT RECIPIENTS WITH IMMUNOSUPPRESSION AND DONOR-SPECIFIC BLOOD
    ANDERSON, CB
    TYLER, JD
    SICARD, GA
    ANDERMAN, CK
    RODEY, GE
    ETHEREDGE, EE
    TRANSPLANTATION, 1984, 38 (06) : 664 - 668
  • [25] The development of donor specific antibodies in renal allograft recipients is associated with immunosuppression reduction
    Rebellato, Lorita M.
    Terasaki, Paul I.
    Ozawa, Mikki
    Briley, Kimberly P.
    Catrou, Paul
    Haisch, Carl E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 315 - 315
  • [26] Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizurnab) in renal transplant recipients
    Nair, MP
    Nampoory, MRN
    Johny, KV
    Costandi, JN
    Abdulhalim, M
    El-Reshaid, W
    Al-Muzairai, I
    Ninan, VT
    Samhan, M
    Al-Mousawi, M
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (05) : 2767 - 2769
  • [27] EFFECT OF DONOR SOURCE ON RENAL-ALLOGRAFT FUNCTION IN CHILDREN ON TRIPLE IMMUNOSUPPRESSION
    LAINE, J
    FYHRQUIST, F
    HOLMBERG, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (10) : 1468 - 1473
  • [28] Benefits of Induction Immunosuppression in Recipients of Acute Renal Failure Donor Kidneys
    Barrett, Meredith
    Smith, Abigail
    Woodside, Kenneth
    Sung, Randall
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 37 - 37
  • [29] Randomized trial of steroid free immunosuppression with basiliximab induction in adult live donor liver transplantation (LDLT)
    Kathirvel, Manikandan
    Mallick, Shweta
    Sethi, Pulkit
    Thillai, Manoj
    Durairaj, Madhu S.
    Nair, Krishnanunni
    Sunny, Aleena
    Mathew, Johns S.
    Varghese, Christi T.
    Chandran, Biju
    Amma, Binoj S. Pillai Thankamony
    Menon, Ramachandran N.
    Balakrishnan, Dinesh
    Gopalakrishnan, Unnikrishnan
    Surendran, Sudhindran
    HPB, 2021, 23 (05) : 666 - 674
  • [30] Triple immunosuppression with or without basiliximab in pediatric renal transplantation: Acute rejection rates at one year
    Duzova, A
    Buyan, N
    Bakkaloglu, M
    Dalgic, A
    Soylemezoglu, O
    Besbas, N
    Bakkaloglu, A
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) : 2878 - 2880
12345